---
title: "Pre-market hot trades in US stocks: Regencell Bioscience up 5.21% pre-market; IBM down 5.15% pre-market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249908849.md"
description: "Regencell Bioscience pre-market rose 5.21%; IBM pre-market fell 5.15%; Garden Stage pre-market rose 63.56%; Oriental Rise pre-market rose 45.52%; Incannex Healthcare pre-market rose 34.65%"
datetime: "2025-07-24T08:33:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249908849.md)
  - [en](https://longbridge.com/en/news/249908849.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249908849.md)
generator: "portal-rs"
---

# Pre-market hot trades in US stocks: Regencell Bioscience up 5.21% pre-market; IBM down 5.15% pre-market

**Pre-market Hot Trades in US Stocks**

Regencell Bioscience is up 5.21% in pre-market trading. Based on recent important news:

1.  On June 16, Regencell Bioscience completed a 38-for-1 stock split, increasing the number of shares available and attracting retail investors, causing the stock price to soar by 283.13%.

2.  On June 17, social media activity increased, with a surge in followers and heightened market attention, leading to further stock price gains.

3.  On June 18, analysis indicated significant stock price volatility, a lack of substantial positive news, and evident speculative behavior, resulting in large fluctuations in the stock price in the short term.

IBM is down 5.15% in pre-market trading. Based on recent important news:

1.  On July 23, IBM announced its second-quarter financial report, where revenue and profit exceeded expectations, but software division sales fell short, leading to a 5% drop in after-hours trading.

2.  On July 23, the market's growth expectations for IBM's software business were not met, exacerbating investor disappointment and causing the stock price to decline.

3.  On July 23, despite strong performance in infrastructure and consulting businesses, it was not enough to offset the negative impact from the software division.

**Top Gainers in Pre-market US Stocks**

Garden Stage is up 63.56% in pre-market trading. Based on recent important news:

1.  On June 19, Garden Stage announced a self-underwritten offering of 6.1 million common shares directly to specific investors, leading to significant stock price volatility.

2.  On June 16, increased market attention on AI applications drove related stocks up, indirectly benefiting Garden Stage.

3.  On June 9, overheated market sentiment led to irrational stock price fluctuations, affecting Garden Stage.

Dongfang Sheng is up 45.52% in pre-market trading. Based on recent key news:

1.  On July 22, Dongfang Sheng announced its public offering pricing, receiving a positive market response and causing a significant stock price increase.

2.  On July 22, stablecoin concept stocks generally rose, boosting related sectors.

3.  On July 22, Opendoor temporarily halted trading during the day, and after resuming, the gains expanded to 10%, reflecting heightened market sentiment.

Incannex Healthcare is up 34.65% in pre-market trading. Based on recent important news:

1.  On May 28, Incannex Healthcare announced an increase in the number of shares to be issued to $50 million under a revised sales agreement, driving the stock price up.

2.  On May 29, Stonegate Capital Partners updated its report showing a reduction in the company's R&D and management expenses, a narrowing of net losses, and increased cash flow, leading to a positive market reaction.

3.  On May 20, the company announced plans to issue over $2.5 million in stock through a sales agreement to support business operations, enhancing investor confidence

### Related Stocks

- [RGC.US](https://longbridge.com/en/quote/RGC.US.md)
- [IBM.US](https://longbridge.com/en/quote/IBM.US.md)

## Related News & Research

- [What will Washington do next if US bond yields keep rising?](https://longbridge.com/en/news/300918164.md)
- [ROI-Oil's new problem isn't supply. It's logistics: Bousso](https://longbridge.com/en/news/300903866.md)
- [ConocoPhillips sees oil price floor rising to $70 a barrel, chairman says](https://longbridge.com/en/news/300916819.md)
- [TECHNICALS-US oil may retest support at $88.78](https://longbridge.com/en/news/300892493.md)
- [Michael Burry Raises Red Flag on Oracle’s $664B Backlog and AI Spending: ‘The Customer Is Now the Lender’](https://longbridge.com/en/news/300913488.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**